Find your PDFs fast.
Welcome to the Pubget Medical Subject Headings (MESH) browser. Click on a topic or subtopic below to explore related papers. In the gold box is the most recent paper about the current MESH term, and below are 20 related papers.
Neoplasms (16):
- Tumor Virus Infections
- Neoplasms, Second Primary
- Neoplasms, Radiation-Induced
- Neoplastic Processes
- Neoplasms, Multiple Primary
- Hamartoma
- Paraneoplastic Syndromes
- Neoplasms by Histologic Type
- Pregnancy Complications, Neoplastic
- Precancerous Conditions
- Neoplasms, Post-Traumatic
- Neoplasms, Experimental
- Cysts
- Neoplastic Syndromes, Hereditary
- Neoplasms, Hormone-Dependent
- Neoplasms by Site
Recent article
Neoplasms
Nature Medicine (17)12 2011
Abstract
We identify a MEK-independent role for RAF in tumor growth. Specifically, in mitotic cells, CRAF becomes phosphorylated on Ser338 and localizes to the mitotic spindle of proliferating tumor cells in vitro as well as in murine tumor models and in biopsies from individuals with cancer. Treatment of tu...
|
PMID: 22081024
PDF is available here.
PDF is available here.
| < More recent | Older article > |
Nature Medicine (17)12 2011
Abstract
We have developed a new type of molecular-targeted cancer therapy, photoimmunotherapy (PIT), that uses a target-specific photosensitizer based on a near-infrared (NIR) phthalocyanine dye, IR700, conjugated to monoclonal antibodies (mAbs) targeting epidermal growth factor receptors. Cell death was in...
|
PMID: 22057348
PDF is available here.
PDF is available here.
Nature Medicine (17)12 2011
Abstract
We identify a MEK-independent role for RAF in tumor growth. Specifically, in mitotic cells, CRAF becomes phosphorylated on Ser338 and localizes to the mitotic spindle of proliferating tumor cells in vitro as well as in murine tumor models and in biopsies from individuals with cancer. Treatment of tu...
|
PMID: 22081024
PDF is available here.
PDF is available here.
Nature Medicine (17)12 2011
Abstract
We have developed a new type of molecular-targeted cancer therapy, photoimmunotherapy (PIT), that uses a target-specific photosensitizer based on a near-infrared (NIR) phthalocyanine dye, IR700, conjugated to monoclonal antibodies (mAbs) targeting epidermal growth factor receptors. Cell death was in...
|
PMID: 22057348
PDF is available here.
PDF is available here.
Nature Medicine (17)12 2011
Abstract
We identify a MEK-independent role for RAF in tumor growth. Specifically, in mitotic cells, CRAF becomes phosphorylated on Ser338 and localizes to the mitotic spindle of proliferating tumor cells in vitro as well as in murine tumor models and in biopsies from individuals with cancer. Treatment of tu...
|
PMID: 22081024
PDF is available here.
PDF is available here.
Nature Medicine (17)12 2011
Abstract
We identify a MEK-independent role for RAF in tumor growth. Specifically, in mitotic cells, CRAF becomes phosphorylated on Ser338 and localizes to the mitotic spindle of proliferating tumor cells in vitro as well as in murine tumor models and in biopsies from individuals with cancer. Treatment of tu...
|
PMID: 22081024
PDF is available here.
PDF is available here.
Nature Medicine (17)12 2011
Abstract
We have developed a new type of molecular-targeted cancer therapy, photoimmunotherapy (PIT), that uses a target-specific photosensitizer based on a near-infrared (NIR) phthalocyanine dye, IR700, conjugated to monoclonal antibodies (mAbs) targeting epidermal growth factor receptors. Cell death was in...
|
PMID: 22057348
PDF is available here.
PDF is available here.
Nature Medicine (17)12 2011
Abstract
We have developed a new type of molecular-targeted cancer therapy, photoimmunotherapy (PIT), that uses a target-specific photosensitizer based on a near-infrared (NIR) phthalocyanine dye, IR700, conjugated to monoclonal antibodies (mAbs) targeting epidermal growth factor receptors. Cell death was in...
|
PMID: 22057348
PDF is available here.
PDF is available here.
Nature Medicine (17)12 2011
Abstract
We identify a MEK-independent role for RAF in tumor growth. Specifically, in mitotic cells, CRAF becomes phosphorylated on Ser338 and localizes to the mitotic spindle of proliferating tumor cells in vitro as well as in murine tumor models and in biopsies from individuals with cancer. Treatment of tu...
|
PMID: 22081024
PDF is available here.
PDF is available here.
Nature Medicine (17)12 2011
Abstract
We have developed a new type of molecular-targeted cancer therapy, photoimmunotherapy (PIT), that uses a target-specific photosensitizer based on a near-infrared (NIR) phthalocyanine dye, IR700, conjugated to monoclonal antibodies (mAbs) targeting epidermal growth factor receptors. Cell death was in...
|
PMID: 22057348
PDF is available here.
PDF is available here.
Nature Medicine (17)12 2011
Abstract
We identify a MEK-independent role for RAF in tumor growth. Specifically, in mitotic cells, CRAF becomes phosphorylated on Ser338 and localizes to the mitotic spindle of proliferating tumor cells in vitro as well as in murine tumor models and in biopsies from individuals with cancer. Treatment of tu...
|
PMID: 22081024
PDF is available here.
PDF is available here.
Nature Medicine (17)12 2011
Abstract
We have developed a new type of molecular-targeted cancer therapy, photoimmunotherapy (PIT), that uses a target-specific photosensitizer based on a near-infrared (NIR) phthalocyanine dye, IR700, conjugated to monoclonal antibodies (mAbs) targeting epidermal growth factor receptors. Cell death was in...
|
PMID: 22057348
PDF is available here.
PDF is available here.
Nature Medicine (17)12 2011
Abstract
We identify a MEK-independent role for RAF in tumor growth. Specifically, in mitotic cells, CRAF becomes phosphorylated on Ser338 and localizes to the mitotic spindle of proliferating tumor cells in vitro as well as in murine tumor models and in biopsies from individuals with cancer. Treatment of tu...
|
PMID: 22081024
PDF is available here.
PDF is available here.
Nature Medicine (17)12 2011
Abstract
We have developed a new type of molecular-targeted cancer therapy, photoimmunotherapy (PIT), that uses a target-specific photosensitizer based on a near-infrared (NIR) phthalocyanine dye, IR700, conjugated to monoclonal antibodies (mAbs) targeting epidermal growth factor receptors. Cell death was in...
|
PMID: 22057348
PDF is available here.
PDF is available here.
Nature Medicine (17)12 2011
Abstract
We identify a MEK-independent role for RAF in tumor growth. Specifically, in mitotic cells, CRAF becomes phosphorylated on Ser338 and localizes to the mitotic spindle of proliferating tumor cells in vitro as well as in murine tumor models and in biopsies from individuals with cancer. Treatment of tu...
|
PMID: 22081024
PDF is available here.
PDF is available here.
Nature Medicine (17)12 2011
Abstract
We identify a MEK-independent role for RAF in tumor growth. Specifically, in mitotic cells, CRAF becomes phosphorylated on Ser338 and localizes to the mitotic spindle of proliferating tumor cells in vitro as well as in murine tumor models and in biopsies from individuals with cancer. Treatment of tu...
|
PMID: 22081024
PDF is available here.
PDF is available here.
Nature Medicine (17)12 2011
Abstract
We have developed a new type of molecular-targeted cancer therapy, photoimmunotherapy (PIT), that uses a target-specific photosensitizer based on a near-infrared (NIR) phthalocyanine dye, IR700, conjugated to monoclonal antibodies (mAbs) targeting epidermal growth factor receptors. Cell death was in...
|
PMID: 22057348
PDF is available here.
PDF is available here.
Nature Medicine (17)12 2011
Abstract
We have developed a new type of molecular-targeted cancer therapy, photoimmunotherapy (PIT), that uses a target-specific photosensitizer based on a near-infrared (NIR) phthalocyanine dye, IR700, conjugated to monoclonal antibodies (mAbs) targeting epidermal growth factor receptors. Cell death was in...
|
PMID: 22057348
PDF is available here.
PDF is available here.